Insider Transactions Reported by 25 Insiders of Aquestive Therapeutics, Inc.

Symbol
AQST on Nasdaq
Location
Warren, NJ

Insiders trading volume in the past year

Aquestive Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Daniel Barber President and CEO, Director $5,572,253 -$553,591 -9% 26 Sep 2025
Alexander Mark Schobel Chief Innovation/Tech Officer $4,804,243 15 Mar 2024
Carl N. Kraus Chief Medical Officer $1,977,325 -$141,904 -6.7% 15 Oct 2025
Peter E. Boyd Chief People Officer $1,767,419 -$212,500 -11% 04 Dec 2025
Cassie Jung Chief Operating Officer $1,698,984 -$784,601 -32% 15 Oct 2025
Melina Cioffi SVP, Regulatory Affairs $1,187,055 02 Dec 2025
LORI J. BRAENDER Chief Legal Officer $1,067,900 07 Mar 2025
Douglas K. Bratton 10%+ Owner $1,033,452 02 Dec 2024
A. ERNEST TOTH JR Chief Financial Officer $899,320 07 Mar 2025
Stephen Wargacki Chief Science Officer $872,622 07 Mar 2025
Sherry Korczynski Chief Commercial Officer $729,250 14 Aug 2025
John Cochran Director $441,678 11 Jun 2025
GREGORY B. BROWN Director $368,475 11 Jun 2025
Matthew W. Davis Chief Development Officer $279,500 10 Nov 2025
Marco Taglietti Director $143,220 11 Jun 2025
Julie Krop Director $143,220 11 Jun 2025
Abigail L. Jenkins Director $143,220 11 Jun 2025
TIMOTHY E. MORRIS Director $143,220 11 Jun 2025
SANTO J. COSTA Director $84,556 20 Jun 2024
James S. Scibetta Director $25,624 15 Jun 2021
Nancy Lurker Director 15 Jun 2021
Keith J. Kendall CEO and President, Director 10 Mar 2022
Theresa Wood SVP-HR and Org. Development 10 Mar 2022
Kenneth Truitt Chief Medical Officer 06 Sep 2022
Ken W. Marshall SVP, Chief Commercial Officer 09 Aug 2023

Recent Insider Transactions by Companies or Individuals for Aquestive Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.